vs
Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and CVR PARTNERS, LP (UAN). Click either name above to swap in a different company.
CVR PARTNERS, LP is the larger business by last-quarter revenue ($131.1M vs $76.4M, roughly 1.7× PROCEPT BioRobotics Corp). CVR PARTNERS, LP runs the higher net margin — -7.8% vs -39.1%, a 31.2% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (11.9% vs -6.1%). PROCEPT BioRobotics Corp produced more free cash flow last quarter ($-12.2M vs $-45.2M). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (31.0% CAGR vs 1.3%).
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
CVR Partners, LP is a leading North American producer of nitrogen-based fertilizer products, primarily urea ammonium nitrate (UAN) and ammonia. It serves agricultural, industrial and commercial markets across the U.S. and Canada, delivering cost-effective, high-quality nutrient solutions for crop production and diverse industrial use cases.
PRCT vs UAN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $76.4M | $131.1M |
| Net Profit | $-29.8M | $-10.3M |
| Gross Margin | 60.6% | 4.4% |
| Operating Margin | -40.6% | -2.2% |
| Net Margin | -39.1% | -7.8% |
| Revenue YoY | 11.9% | -6.1% |
| Net Profit YoY | -58.3% | -156.1% |
| EPS (diluted) | $-0.54 | $-0.98 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $76.4M | $131.1M | ||
| Q3 25 | $83.3M | $163.5M | ||
| Q2 25 | $79.2M | $168.6M | ||
| Q1 25 | $69.2M | $142.9M | ||
| Q4 24 | $68.2M | $139.6M | ||
| Q3 24 | $58.4M | $125.2M | ||
| Q2 24 | $53.4M | $132.9M | ||
| Q1 24 | $44.5M | $127.7M |
| Q4 25 | $-29.8M | $-10.3M | ||
| Q3 25 | $-21.4M | $43.1M | ||
| Q2 25 | $-19.6M | $38.8M | ||
| Q1 25 | $-24.7M | $27.1M | ||
| Q4 24 | $-18.9M | $18.3M | ||
| Q3 24 | $-21.0M | $3.8M | ||
| Q2 24 | $-25.6M | $26.2M | ||
| Q1 24 | $-26.0M | $12.6M |
| Q4 25 | 60.6% | 4.4% | ||
| Q3 25 | 64.8% | 37.0% | ||
| Q2 25 | 65.4% | 32.4% | ||
| Q1 25 | 63.9% | 29.7% | ||
| Q4 24 | 64.0% | 23.8% | ||
| Q3 24 | 63.2% | 14.7% | ||
| Q2 24 | 59.0% | 30.0% | ||
| Q1 24 | 56.2% | 21.4% |
| Q4 25 | -40.6% | -2.2% | ||
| Q3 25 | -27.8% | 31.0% | ||
| Q2 25 | -28.0% | 27.5% | ||
| Q1 25 | -39.7% | 24.2% | ||
| Q4 24 | -28.9% | 18.4% | ||
| Q3 24 | -38.4% | 8.8% | ||
| Q2 24 | -50.3% | 25.3% | ||
| Q1 24 | -62.1% | 15.7% |
| Q4 25 | -39.1% | -7.8% | ||
| Q3 25 | -25.7% | 26.3% | ||
| Q2 25 | -24.7% | 23.0% | ||
| Q1 25 | -35.8% | 19.0% | ||
| Q4 24 | -27.6% | 13.1% | ||
| Q3 24 | -35.9% | 3.0% | ||
| Q2 24 | -48.0% | 19.7% | ||
| Q1 24 | -58.3% | 9.9% |
| Q4 25 | $-0.54 | $-0.98 | ||
| Q3 25 | $-0.38 | $4.08 | ||
| Q2 25 | $-0.35 | $3.67 | ||
| Q1 25 | $-0.45 | $2.56 | ||
| Q4 24 | $-0.34 | $1.73 | ||
| Q3 24 | $-0.40 | $0.36 | ||
| Q2 24 | $-0.50 | $2.48 | ||
| Q1 24 | $-0.51 | $1.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $286.5M | $69.2M |
| Total DebtLower is stronger | $51.6M | $569.1M |
| Stockholders' EquityBook value | $365.9M | — |
| Total Assets | $508.1M | $969.5M |
| Debt / EquityLower = less leverage | 0.14× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $286.5M | $69.2M | ||
| Q3 25 | $294.3M | $156.2M | ||
| Q2 25 | $302.7M | $114.4M | ||
| Q1 25 | $316.2M | $121.8M | ||
| Q4 24 | $333.7M | $90.9M | ||
| Q3 24 | $196.8M | $110.5M | ||
| Q2 24 | $214.1M | $47.5M | ||
| Q1 24 | $225.6M | $64.6M |
| Q4 25 | $51.6M | $569.1M | ||
| Q3 25 | $51.6M | $569.1M | ||
| Q2 25 | $51.5M | $569.2M | ||
| Q1 25 | $51.5M | $569.3M | ||
| Q4 24 | $51.5M | $568.0M | ||
| Q3 24 | $51.4M | $547.7M | ||
| Q2 24 | $51.4M | $547.6M | ||
| Q1 24 | $51.4M | $547.4M |
| Q4 25 | $365.9M | — | ||
| Q3 25 | $380.3M | — | ||
| Q2 25 | $385.8M | — | ||
| Q1 25 | $389.2M | — | ||
| Q4 24 | $402.2M | — | ||
| Q3 24 | $241.2M | — | ||
| Q2 24 | $251.8M | — | ||
| Q1 24 | $264.0M | — |
| Q4 25 | $508.1M | $969.5M | ||
| Q3 25 | $511.5M | $1.0B | ||
| Q2 25 | $513.1M | $998.0M | ||
| Q1 25 | $519.4M | $1.0B | ||
| Q4 24 | $534.0M | $1.0B | ||
| Q3 24 | $374.1M | $986.6M | ||
| Q2 24 | $374.4M | $959.4M | ||
| Q1 24 | $382.9M | $972.2M |
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.20× | — | ||
| Q1 24 | 0.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.3M | $-21.6M |
| Free Cash FlowOCF − Capex | $-12.2M | $-45.2M |
| FCF MarginFCF / Revenue | -15.9% | -34.5% |
| Capex IntensityCapex / Revenue | 2.4% | 18.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-58.3M | $98.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.3M | $-21.6M | ||
| Q3 25 | $-6.6M | $91.7M | ||
| Q2 25 | $-15.0M | $24.1M | ||
| Q1 25 | $-17.0M | $55.4M | ||
| Q4 24 | $-32.4M | $12.8M | ||
| Q3 24 | $-18.8M | $86.7M | ||
| Q2 24 | $-15.7M | $8.6M | ||
| Q1 24 | $-32.3M | $42.4M |
| Q4 25 | $-12.2M | $-45.2M | ||
| Q3 25 | $-9.5M | $80.1M | ||
| Q2 25 | $-17.8M | $18.4M | ||
| Q1 25 | $-18.8M | $45.5M | ||
| Q4 24 | $-33.6M | $-5.6M | ||
| Q3 24 | $-19.0M | $82.3M | ||
| Q2 24 | $-16.8M | $2.4M | ||
| Q1 24 | $-34.2M | $34.3M |
| Q4 25 | -15.9% | -34.5% | ||
| Q3 25 | -11.4% | 49.0% | ||
| Q2 25 | -22.5% | 10.9% | ||
| Q1 25 | -27.2% | 31.9% | ||
| Q4 24 | -49.2% | -4.0% | ||
| Q3 24 | -32.6% | 65.7% | ||
| Q2 24 | -31.4% | 1.8% | ||
| Q1 24 | -76.9% | 26.9% |
| Q4 25 | 2.4% | 18.0% | ||
| Q3 25 | 3.4% | 7.1% | ||
| Q2 25 | 3.5% | 3.4% | ||
| Q1 25 | 2.7% | 6.9% | ||
| Q4 24 | 1.7% | 13.1% | ||
| Q3 24 | 0.4% | 3.6% | ||
| Q2 24 | 2.0% | 4.6% | ||
| Q1 24 | 4.4% | 6.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.13× | ||
| Q2 25 | — | 0.62× | ||
| Q1 25 | — | 2.04× | ||
| Q4 24 | — | 0.70× | ||
| Q3 24 | — | 22.78× | ||
| Q2 24 | — | 0.33× | ||
| Q1 24 | — | 3.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRCT
| Hand Pieces And Other Consumables | $34.1M | 45% |
| System Sales And Rentals | $27.5M | 36% |
| Other | $9.8M | 13% |
| Service Revenue | $5.0M | 7% |
UAN
| Product UAN | $64.7M | 49% |
| Product Ammonia | $50.5M | 39% |
| Products Other | $8.5M | 7% |
| Product Urea Products | $7.4M | 6% |
